| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-178 |
Sentence |
denotes |
The C-terminal N-glycosylation sites of the human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, adn -VI) are necessary for the expression of full enzyme activity. |
| T1 |
0-178 |
Sentence |
denotes |
The C-terminal N-glycosylation sites of the human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, adn -VI) are necessary for the expression of full enzyme activity. |
| T1 |
0-178 |
Sentence |
denotes |
The C-terminal N-glycosylation sites of the human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, adn -VI) are necessary for the expression of full enzyme activity. |
| TextSentencer_T2 |
179-288 |
Sentence |
denotes |
The alpha1,3/4-fucosyltransferases are involved in the synthesis of fucosylated cell surface glycoconjugates. |
| T2 |
179-288 |
Sentence |
denotes |
The alpha1,3/4-fucosyltransferases are involved in the synthesis of fucosylated cell surface glycoconjugates. |
| T2 |
179-288 |
Sentence |
denotes |
The alpha1,3/4-fucosyltransferases are involved in the synthesis of fucosylated cell surface glycoconjugates. |
| TextSentencer_T3 |
289-431 |
Sentence |
denotes |
Human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, and -VI) contain two conserved C-terminal N-glycosylation sites (hFucTIII: |
| T3 |
289-431 |
Sentence |
denotes |
Human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, and -VI) contain two conserved C-terminal N-glycosylation sites (hFucTIII: |
| T3 |
289-431 |
Sentence |
denotes |
Human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, and -VI) contain two conserved C-terminal N-glycosylation sites (hFucTIII: |
| TextSentencer_T4 |
432-458 |
Sentence |
denotes |
Asn154 and Asn185; hFucTV: |
| T4 |
432-458 |
Sentence |
denotes |
Asn154 and Asn185; hFucTV: |
| T4 |
432-458 |
Sentence |
denotes |
Asn154 and Asn185; hFucTV: |
| TextSentencer_T5 |
459-490 |
Sentence |
denotes |
Asn167 and Asn198; and hFucTVI: |
| T5 |
459-490 |
Sentence |
denotes |
Asn167 and Asn198; and hFucTVI: |
| T5 |
459-490 |
Sentence |
denotes |
Asn167 and Asn198; and hFucTVI: |
| TextSentencer_T6 |
491-510 |
Sentence |
denotes |
Asn153 and Asn184). |
| T6 |
491-510 |
Sentence |
denotes |
Asn153 and Asn184). |
| T6 |
491-510 |
Sentence |
denotes |
Asn153 and Asn184). |
| TextSentencer_T7 |
511-662 |
Sentence |
denotes |
In the present study, we have analyzed the functional role of these potential N-glycosylation sites, laying the main emphasis on the sites in hFucTIII. |
| T7 |
511-662 |
Sentence |
denotes |
In the present study, we have analyzed the functional role of these potential N-glycosylation sites, laying the main emphasis on the sites in hFucTIII. |
| T7 |
511-662 |
Sentence |
denotes |
In the present study, we have analyzed the functional role of these potential N-glycosylation sites, laying the main emphasis on the sites in hFucTIII. |
| TextSentencer_T8 |
663-857 |
Sentence |
denotes |
Tunicamycin treatment completely abolished hFucTIII enzyme activity while castanospermine treatment diminished hFucTIII enzyme activity to approximately 40% of the activity of the native enzyme. |
| T8 |
663-857 |
Sentence |
denotes |
Tunicamycin treatment completely abolished hFucTIII enzyme activity while castanospermine treatment diminished hFucTIII enzyme activity to approximately 40% of the activity of the native enzyme. |
| T8 |
663-857 |
Sentence |
denotes |
Tunicamycin treatment completely abolished hFucTIII enzyme activity while castanospermine treatment diminished hFucTIII enzyme activity to approximately 40% of the activity of the native enzyme. |
| TextSentencer_T9 |
858-1101 |
Sentence |
denotes |
To further analyze the role of the conserved N-glycosylation sites in hFucTIII, -V, and -VI, we made a series of mutant genomic DNAs in which the asparagine residues in the potential C-terminal N-glycosylation sites were replaced by glutamine. |
| T9 |
858-1101 |
Sentence |
denotes |
To further analyze the role of the conserved N-glycosylation sites in hFucTIII, -V, and -VI, we made a series of mutant genomic DNAs in which the asparagine residues in the potential C-terminal N-glycosylation sites were replaced by glutamine. |
| T9 |
858-1101 |
Sentence |
denotes |
To further analyze the role of the conserved N-glycosylation sites in hFucTIII, -V, and -VI, we made a series of mutant genomic DNAs in which the asparagine residues in the potential C-terminal N-glycosylation sites were replaced by glutamine. |
| TextSentencer_T10 |
1102-1198 |
Sentence |
denotes |
Subsequently, the hFucTIII, -V, and -VI wild type and the mutants were expressed in COS-7 cells. |
| T10 |
1102-1198 |
Sentence |
denotes |
Subsequently, the hFucTIII, -V, and -VI wild type and the mutants were expressed in COS-7 cells. |
| T10 |
1102-1198 |
Sentence |
denotes |
Subsequently, the hFucTIII, -V, and -VI wild type and the mutants were expressed in COS-7 cells. |
| TextSentencer_T11 |
1199-1340 |
Sentence |
denotes |
All the mutants exhibited lower enzyme activity than the wild type and elimination of individual sites had different effects on the activity. |
| T11 |
1199-1340 |
Sentence |
denotes |
All the mutants exhibited lower enzyme activity than the wild type and elimination of individual sites had different effects on the activity. |
| T11 |
1199-1340 |
Sentence |
denotes |
All the mutants exhibited lower enzyme activity than the wild type and elimination of individual sites had different effects on the activity. |
| TextSentencer_T12 |
1341-1461 |
Sentence |
denotes |
The mutations did not affect the protein level of the mutants in the cells, but reduced the molecular mass as predicted. |
| T12 |
1341-1461 |
Sentence |
denotes |
The mutations did not affect the protein level of the mutants in the cells, but reduced the molecular mass as predicted. |
| T12 |
1341-1461 |
Sentence |
denotes |
The mutations did not affect the protein level of the mutants in the cells, but reduced the molecular mass as predicted. |
| TextSentencer_T13 |
1462-1630 |
Sentence |
denotes |
Kinetic analysis of hFucTIII revealed that lack of glycosylation at Asn185 did not change the Km values for the oligosaccharide acceptor and the nucleotide sugar donor. |
| T13 |
1462-1630 |
Sentence |
denotes |
Kinetic analysis of hFucTIII revealed that lack of glycosylation at Asn185 did not change the Km values for the oligosaccharide acceptor and the nucleotide sugar donor. |
| T13 |
1462-1630 |
Sentence |
denotes |
Kinetic analysis of hFucTIII revealed that lack of glycosylation at Asn185 did not change the Km values for the oligosaccharide acceptor and the nucleotide sugar donor. |
| TextSentencer_T14 |
1631-1806 |
Sentence |
denotes |
The present study demonstrates that hFucTIII, -V, and -VI require N-glycosylation at the two conserved C-terminal N-glycosylation sites for expression of full enzyme activity. |
| T14 |
1631-1806 |
Sentence |
denotes |
The present study demonstrates that hFucTIII, -V, and -VI require N-glycosylation at the two conserved C-terminal N-glycosylation sites for expression of full enzyme activity. |
| T14 |
1631-1806 |
Sentence |
denotes |
The present study demonstrates that hFucTIII, -V, and -VI require N-glycosylation at the two conserved C-terminal N-glycosylation sites for expression of full enzyme activity. |